A detailed history of Johnson Financial Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 39,148 shares of ABT stock, worth $4.57 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
39,148
Previous 14,499 170.0%
Holding current value
$4.57 Million
Previous $1.65 Million 146.93%
% of portfolio
0.2%
Previous 0.09%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $2.48 Million - $2.77 Million
24,649 Added 170.0%
39,148 $4.07 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $244,777 - $270,345
-2,235 Reduced 13.36%
14,499 $1.65 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $61,239 - $74,961
-679 Reduced 3.9%
16,734 $1.84 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $22,927 - $27,508
-240 Reduced 1.36%
17,413 $1.69 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $341,946 - $380,999
-3,393 Reduced 16.12%
17,653 $1.92 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $542,706 - $638,798
5,603 Added 36.28%
21,046 $2.13 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $28,993 - $34,013
305 Added 2.01%
15,443 $1.7 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $93,663 - $108,445
968 Added 6.83%
15,138 $1.49 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $1,939 - $2,344
-19 Reduced 0.13%
14,170 $1.54 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $216,638 - $264,176
1,900 Added 15.46%
14,189 $1.68 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $247,003 - $302,441
-2,138 Reduced 14.82%
12,289 $1.73 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $28,115 - $31,103
-241 Reduced 1.64%
14,427 $1.7 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $52,154 - $61,393
-493 Reduced 3.25%
14,668 $1.7 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $309,432 - $364,557
-2,843 Reduced 15.79%
15,161 $1.82 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $686,070 - $747,620
6,534 Added 56.97%
18,004 $1.97 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $17,136 - $20,811
-187 Reduced 1.6%
11,470 $1.25 Million
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $645,178 - $825,748
-8,426 Reduced 41.96%
11,657 $1.07 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $50,444 - $73,763
803 Added 4.16%
20,083 $1.59 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $530,884 - $590,998
6,762 Added 54.02%
19,280 $1.68 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $12,276 - $13,311
150 Added 1.21%
12,518 $1.05 Million
Q2 2019

Aug 09, 2019

SELL
$72.88 - $85.0 $7,506 - $8,755
-103 Reduced 0.83%
12,368 $1.04 Million
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $64,961 - $78,538
981 Added 8.54%
12,471 $997,000
Q4 2018

Feb 11, 2019

SELL
$65.56 - $74.27 $6,556 - $7,427
-100 Reduced 0.86%
11,490 $832,000
Q3 2018

Nov 09, 2018

SELL
$60.81 - $73.36 $38,979 - $47,023
-641 Reduced 5.24%
11,590 $850,000
Q1 2018

May 07, 2018

SELL
$56.27 - $63.62 $58,014 - $65,592
-1,031 Reduced 7.77%
12,231 $733,000
Q4 2017

Feb 12, 2018

SELL
$53.68 - $57.47 $9,394 - $10,057
-175 Reduced 1.3%
13,262 $757,000
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $645,782 - $720,760
13,437
13,437 $716,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.